Cited by 77Trypanosoma species research and implicationsVector-borne infectious diseasesSleep and Wakefulness Research

The duality of sleeping sickness: focusing on sleep

Buguet, A, Bourdon, L, Bouteille, B, Cespuglio, R, Vincendeau, P, Radomski, M.W, Dumas, M·2001·Sleep Medicine Reviews

Abstract

Sleeping sickness, once under control, is a re-emergent endemic parasitic disease in intertropical Africa. Its originality resides in its duality. Two trypanosome groups (Trypanososma brucei gambiense vs.rhodesiense ) are transmitted to humans by tsetse flies from two geographical areas (Western and Central Africa humid forest vs. Eastern Africa arboreous savannah), provoking a slowly or a rapidly evolutive disease. The two stage (haemolymphatic vs. neurological invasion) pathogenic evolution leads to the duality of the immune response, depending on the host-parasite inter-relation differences in the blood and the brain. In the blood, the immune processes involved are both specific (anti-variant surface glycoprotein (VSG) antibodies) and non-specific (complement-mediated lysis, opsonification-facilitated phagocytosis and antibody dependent cell-mediated cytotoxicity). Although macrophages are activated in the blood and infiltrate the brain, nitric oxide decreases in the blood and increases in the brain, with a breakage in the blood-brain barrier, leading to brain lesions through the production of deleterious molecules. Prophylactic means are affected by the duality of pathogenic processes. This finally leads to a two stage disease (haemolymphatic vs. neurological) with two different therapeutic strategies. The sleep-wake cycle and other biological rhythms are also marked by the disappearance of circadian rhythmicity demasking basic ultradian activities and relationships, such as the interdependence of endocrine profiles and the sleep-wake alternation. 2001 Harcourt Publishers Ltd

Integrity signals

Registry

Crossref · 10.1053/smrv.2000.0130

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This insomnia sample showed objective PSG-derived sleep impairments, indicated by increased sleep onset latency, reduced total sleep time, and decreased sleep efficiency compared with healthy sleepers.

    “This insomnia sample also showed objective PSG-derived sleep impairments, as indicated by increased sleep onset latency, reduced total sleep time, and decreased sleep efficiency compared with healthy sleepers”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [84]

  • Another study reported an increase of IL-6 levels during the nighttime, rather than daytime, in 11 individuals with primary insomnia compared with age- and sex-matched healthy sleepers.

    “another study reported an increase of IL-6 levels during the nighttime, rather than daytime, in 11 individuals with primary insomnia compared with age- and sex-matched healthy sleepers”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [84]

  • Greater PSG-derived nocturnal wake time was related to higher IL-6 levels.

    “greater PSG-derived nocturnal wake time was related to higher IL-6 levels”

    From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [84]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Buguet, A., Bourdon, L., Bouteille, B., Cespuglio, R., Vincendeau, P., Radomski, M. W., & Dumas, M.
Affiliations
Lyon 1 Université (FR)
Venue
Sleep Medicine Reviews
Publisher
Elsevier BV
Published
2001-04
Volume
5
Issue
2
Pages
139-153
ISSN
1087-0792 (ISSN-L)
OpenAlex
W2134855562
Cited by
77
References
59
Citations by year
2024: 3 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 4 · 2012: 9
FWCI
1.75
Type
journal article
Language
en
Open access
closed
Locations
  • Sleep Medicine Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Epidemiology › Trypanosoma species research and implications
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Keywords
sleeping sickness, trypanosomiasis, Trypanosoma brucei gambiense, Trypanosoma brucei rhodesiense, tsetse flies, immune response, variant surface glycoprotein, complement-mediated lysis, opsonization, antibody-dependent cellular cytotoxicity, macrophages, nitric oxide, blood-brain barrier, sleep-wake cycle, circadian rhythm, ultradian rhythms, hormonal profile, prophylaxis, treatment options

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review